Your tax dollars are getting spent on weight-loss drugs like Ozempic, and the total is adding up

• As demand for weight loss drugs grows, so too do the costs for some insurance plans.
• That might be weighing on taxpayers, who fund Medicaid and state health plans.
• North Carolina State Treasurer Dale Folwell said the state's health plan is "under financial siege."

The Ozempic craze is continuing to cascade across America — and local governments are worried taxpayers can't afford to fund it much longer.

Over the past year, demand for weight-loss drugs like Ozempic, Wegovy, and similar types of medications known as GLP-1s have surged as Americans fawned over the drugs' quick results to shed some pounds.